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We investigated the necessity of preparation for blood transfusion in gastric cancer surgery
to save costs for blood typing, antibody screening, cross-matching, and disposal of the
blood product. The subjects of the study were 52 patients who underwent gastric cancer
surgery at our department between 2000 and 2004. The requirement for blood transfusion
during surgery was investigated in terms of patient characteristics, hemoglobin before sur-
gery, and performance status as well as treatment regimen. Furthermore, economic effects
were investigated when typing and screening (T&S) were performed instead of typing and
cross-matching (T&X). Of 9 patients who received blood transfusion, 8 had gastric cancer of
stage IIIB or higher, or underwent combined resection. Blood transfusion was not used in
surgery for patients with early gastric cancer. The volumes of blood prepared, lost, and dis-
posed of in 28 patients who underwent T&X were 831.3 249.4, 219.3 228.5 and
600 333.1 ml, respectively, whereas the blood loss in 24 patients who underwent T&S
was 161.1 95.6 ml; this difference had a major economic effect. The practice of T&S for
patients undergoing gastric surgery in the absence of combined resection for early gastric
cancer seems to be a safe and cost-effective practice that abrogates disposal of blood in
hospital management.
ª 2008 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction system; thus reduction of health care costs is likely to becomeThe national health insurance system currently in operation
in Japan covers all Japanese citizens and provides good health
care for the population. However, financial problems have
been pointed out. Key issues for hospital management include
simplification of health care deliverywithout affecting patient
care, and expansion of the comprehensive health insurancery, DaisanHospital, The Ji
(3251); fax: þ81 3 3480 829
).
al Associates Ltd. Publishincreasingly important. In gastric cancer surgery, blood trans-
fusion is not usually required, but blood products are often
prepared preoperatively according to the Maximum Surgical
Blood Order Schedule (MSBOS).1,2 This results in wasted costs
for blood typing, antibody screening, cross-matching, and
disposal of the blood product if transfusion is not performed.
However, health care providers must prepare for thekei University School ofMedicine, 4-11-1, Izumihon-cho, Komae-si,
5.
ed by Elsevier Ltd. All rights reserved.
Table 2 – Treatment regimen
Surgical procedure (cases)
Distal gastrectomy 24
Total gastrectomy 13
Proxymal gastrectomy 3
Partial gastrectomy 2
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ber of financial pressures in the current system of medical fee
payments. To examine this issue further, we performed a ret-
rospective study of blood transfusion, and investigated the ne-
cessity of preparation for blood transfusion in gastric cancer
surgery.Othersa 10
Lymph node dissection (cases)
(D0/D1/D1þ a/D2) 11/8/21/12
Combined resectionb (cases) 5
Role of senior
surgeon (cases)
(Operator/teaching assistant) 14/38
a Bypass in 7, enterostomy in 2 and exploratory laparotomy in 1
patient.
b Gallbladder: 3, Spleen: 1, Colon: 1.2. Patients and methods
The subjects of the study were 52 patients who underwent
gastric cancer surgery which was performed or participated
by a senior surgeon specialized in digestive organs (Y.H.) at
the Department of Surgery, Utsunomiya National Hospital be-
tween January 2000 and June 2004. The requirement for blood
transfusion during surgery was investigated in terms of
patient background [age, sex, obesity index (BMI), extent
of disease (stage), hemoglobin before surgery, and severity of
co-morbidity (PS)] and treatment regimen (surgical procedure,
lymph node dissection, and whether the operating surgeon
was a senior surgeon or of a junior staff). Furthermore, eco-
nomic effects were investigated based on the volumes of
blood loss during surgery, blood given during surgery, blood
prepared preoperatively and blood disposed of postopera-
tively, and whether typing and screening (T&S) was per-
formed. Anesthesiologist judged whether to transfuse while
operating based on amount of the hemorrhage, level of ane-
mia, and cardiovascular condition.
The 52 patients (30 males and 22 females) had a mean age
of 67.2 10.9 years, and a mean BMI of 21.4 2.97, whose gas-
tric cancer was Stage I, II, III and IV in 25, 6, 5 and 16 patients,
respectively. The mean hemoglobin before surgery was
12.6 2.03 g/dl, and the PS 0, 1, 2, and 3 in 6, 25, 5 and 6 pa-
tients, respectively (Table 1). The surgical procedure per-
formed consisted of distal gastrectomy in 24, proxymal
gastrectomy in 3, total gastrectomy in 13, partial gastrectomy
in 2, and palliative surgery such as bypass surgery or enteros-
tomy in 10 patients, respectively. The degree of lymph node
dissection was D0, D1, D1þ a and D2 in 11, 8, 21 and 12 pa-
tients, respectively. Of the 52 surgeries, 14 were performed
by senior surgeons (Table 2).3. Results
Characteristics of the patients who received blood transfusion
are shown in Table 3. Of the 9 patients who received bloodTable 1 – Patients’ background
Age (years) 67.2 10.9
Sex (male:female) 30:22
BMI 21.4 2.97
Hb (g/dl) 12.6 2.03
PS (0/1/2/3) 6/25/5/6
Stage (I/II/III/IV) (patients) 25/6/5/16
BMI, body mass index; Hb, hemoglobin before surgery; PS, perfor-
mance status.transfusion, 8 had gastric cancer of stage IIIB or higher, or un-
derwent combined resection (Table 4). Blood transfusion was
not used in surgery for patients with early gastric cancer.
The volumes of blood prepared, lost, and disposed of in 28
patients who underwent typing and cross-matching (T&X)
rather than T&S were 831.3 249.4, 219.3 228.5 and
600 333.1 ml, respectively, whereas the blood loss in 24 pa-
tients who underwent T&Swas 161.1 95.6 ml; this difference
had a major economic effect that contributed to an average
saving of 36,420 13,650 yen when T&S was performed (Table
5). The differences in the background between the patients
who underwent T&X and T&S are shown in Table 6. We
tend to prepare the blood before surgery for the patients
with higher stage, anemia and who underwent total gastrec-
tomy (Table 6).4. Discussion
The quality of surgery performed by senior surgeons or by ju-
nior staffs under senior surgeon’s supervision did not appear
to be relevant to blood transfusion requirement. Also, previ-
ous reports have shown no effect of the seniority of the sur-
geon on mortality and morbidity.3 Our data showed that
surgery for early gastric cancer did not require blood transfu-
sion, regardless of the technique used or performance of
lymph node dissection. Bleeding from the primary lesion, de-
terioration of the general condition of the patient, and nutri-
tional disorders were absent in patients with the early
gastric cancer, which may account for this observation. In ad-
dition, anemia is unlikely to develop before surgery in these
patients, and combined resection is unnecessary. These facts
further reduced the need for blood transfusion; however, it
should be noted that surgery for early gastric cancer accompa-
nied by bleeding at the anastomosis site and/or coagulopathy
requiring blood transfusion has been reported.4 In contrast to
early gastric cancer, preoperative anemia is likely in patients
with gastric cancer of more than Stage IIIB, due to bleeding
from primary lesions, general deterioration, or nutritional dis-
orders. Furthermore, the incidence rate of anemia in patients
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Table 4 – Relationship between stage and blood
transfusion during operation
N0 N1 N2 N3
T1 IA (0/21) IB (0/0) II (0/0)
T2 IB (1/4) II (1/6) IIIA (0/3)
T3 II (0/0) IIIA (0/0) IIIB (1/2)
T4 IIIA (0/0) IIIB (0/0)
H1,P1 CY1,M1 IV (6/16)
Table 5 – Economic effects of typing and screening
T&X(n¼ 28) T&S (n¼ 24)
Prepared blood (ml) 831.3 249.4a 0
Blood loss (ml) 219.3 228.5 161.1 95.6
Disposed blood (ml) 600.0 333.1 0
Blood transfusion (ml) 733.3 547.7b 0
T&X, typing and cross-matching; T&S, typing and screening.
a Mean  SD.
b Blood transfusion given in 9 patients.
i n t e r n a t i o n a l j o u r n a l o f s u r g e r y 6 ( 2 0 0 8 ) 2 3 4 – 2 3 7236with gastric cancer may increase with progress of the
disease,5–7 and invasion of other organs may require com-
bined resection, thereby increasing the need for blood
transfusion.8,9
In cases of elective surgery where the amount of blood loss
is from 500 to 600 ml and the chance of a requirement for
blood transfusion during surgery is less than 30%, only screen-
ing for the ABO blood type, the Rh (D) factor, and irregular an-
tibodies should be conducted. If the patient has Rh-positive
blood and has no irregular antibodies, cross-matching is un-
necessary. If urgent blood transfusion is needed, cross-match-
ing (primary test) can be conducted using the rapid
physiological saline method, after which compatible blood
transfusion can be performed using appropriate blood prod-
ucts. This approach is referred to as the typing and screening
method. On the other hand, in cases of elective surgery for
which it is certain that blood transfusion will be necessary,
the volume of blood transfused (to compensate for blood
loss) and the volume of blood prepared are based on previous
surgeries conducted at the hospital, with preparation by
cross-matching of approximately 1.5 times the average vol-
ume of blood transfused. This protocol is known as the Maxi-
mumSurgical BloodOrder Schedule (MSBOS) approach. In this
research, the amount of the average hemorrhage of the stom-
ach cancer operation by T&X was 219.3 228.5, T&S was
161.1 95.6 ml, and it is thought that the preparation transfu-
sion of about 400 ml is appropriate. However, there is a possi-
bility of an unexpected hemorrhage when the spleen and the
pancreas tail were excised because of permeation in Stage IV.
The volume of blood prepared, the blood loss, and the vol-
ume of blood disposed of in patients who underwent T&X
were 831.3 249.4, 219.3 228.5 and 600 333.1 ml, respec-
tively, suggesting that preoperative estimation of blood loss
and required volume of blood is difficult, which resulted in
Table 6 – Background between patients who underwent
T&X or T&S
T&X (n¼ 28) T&S (n¼ 24)
Stage (I/II/III/IV) 8/5/4/11 15/1/1/7
Surgical procedure (cases)
Partial gastrectomy 12 12
Total gastrectomy 11 3
Others 5 9
Combined resection (cases) Colon: 1, Spleen: 1 Gallbladder: 3
Lymph nodes
dissected (0/1a/2/3)
6/11/11/0 6/17/1/0
Hb before surgery (g/dl) 11.9 2.28 13.4 1.58
BMI 21.2 3.43 21.5 2.63
Senior operator (Cases) 5 (17.9%) 9 (37.5%)
T&X, typing and cross-matching; T&S, typing and screening.
a Includes þa, b.
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necessary. Blood loss decreased to 161.1 95.6 ml in patients
for whom T&S was conducted (24 patients). This suggests
that there was a tendency to prepare blood transfusion before
surgery for the patients with advanced stage, anemia andwho
undergoes total gastrectomy.10,11 Moreover, since one of the
risk factors for in-hospital mortality after gastric cancer sur-
gery is the amount of blood transfused during surgery,12–14
T&S may become a good index which forecasts about postop-
erative course.
In conclusion, the practice of T&S for patients undergoing
gastric surgery in the absence of combined resection for early
gastric cancer seems to be a safe and cost-effective practice
that abrogates disposal of blood in hospital management.Conflict of interest
None.
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